Skip to main content

Table 2 Results and outcome depending on the type of transplantationa

From: Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis

Authors

Brinkman et al.

Abinum et al.

Silva et al.

Year of publication

2007

2009

2017

Number of patients

22

7

16

Location

Netherlands

UK

UK

HLA donor

Autologous stem cell transplantation (with T cell depletion)

Autologous stem cell transplantation (with T cell depletion)

MUDb 9/16

MSD: 4/16

mMUD: 3/16

Age at HSCT (median)

9.1 years (range 4.2 to 18.2 years)

10.8 years (range 6 to 18 years)

21.5 months (range, 5 months to 12 years)

Follow up (median)

70 months (range 13–135 months)

80 months (range 60–96 months)

29 months (range, 2.8–8 years)

Deaths

2d

1e

2f

Complete clinical remission

8/20

4/6

11/14

Partial responders

7/20

0/6

1/14

Relapse of the disease

5/20

2/6

1/14

Infections:

19/22

4/7

10/16

Viralc (CMV, HSV, EBV, VZV, BK virus)

25

6

10

Bacterial

8

NC

3

Fungal

2

NC

1

Allo/auto-immune complications

1/6

4/14

GVHD (grade II-IV)

3/16

  1. a Two other cases report of autologous hematopoietic stem cell transplantation
  2. - Mistric et al. (Vntir Lek, 1999) which was a success
  3. - Quartier.P et al. (Lancet, 1999), the child died from toxoplasma infection
  4. bMUD Matched Unrelated Donor, MSD Matched Sibling Donor, mMUD Mismatched Unrelated Donor
  5. c HSV herpes simplex virus, CMV cytomegalovirus, EBV Epstein-Barr virus, VZV Varicella zoster virus
  6. d Two children died from Macrophage Activation Syndrome (P1 at D + 18, P2 at D + 120)
  7. e One patient died 4 months post-transplant from disseminated adenovirus reactivation
  8. f One child died from invasive fungal infection and one from sepsis twenty months after HSCT